Intraarticular vs. extraarticular ropivacaine infusion following high-dose local infiltration analgesia after total knee arthroplasty: A randomized double-blind study by Dobrydnjov, Igor et al.
692  Acta Orthopaedica 2011; 82 (6): 692–698
Intraarticular vs. extraarticular ropivacaine infusion following high-
dose local infiltration analgesia after total knee arthroplasty
A randomized double-blind study
Igor Dobrydnjov1, Christian Anderberg1, Christer Olsson1, Olga Shapurova1, Krister Angel1, and Stefan 
Bergman2 
1Department of Rheumasurgery and 2Research and Development Centre, Spenshult Hospital, Oskarström, Sweden
Correspondence: igor.dobrydnjov@spenshult.se    
Submitted 10-12-06. Accepted 11-06-28
Open Access - This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, 
distribution, and reproduction in any medium, provided the source is credited.
DOI 10.3109/17453674.2011.625535
Background and purpose   Ropivacaine infusion following high-
volume local infiltration analgesia has been shown to be effective 
after total knee arthroplasty, but the optimum site of adminis-
tration of ropivacaine has not been evaluated. We compared the 
effects of intraarticular and extraarticular adminstration of the 
local anesthetic for postoperative supplementation of high-vol-
ume local infiltration analgesia.
Patients and methods   In this double-blind study, 36 rheumatic 
patients aged 51–78 years with physical status ASA 2–3 who 
were scheduled for total knee arthroplasty were randomized into 
2 groups. All patients received wound infiltration at the end of 
surgery with 300 mg ropivacaine, 30 mg ketorolac, and 0.5 mg 
epinephrine (total volume 156 mL). A tunneled catheter was ran-
domly placed either extraarticularly or intraarticularly. Continu-
ous infusion of ropivacain (0.5%, 2 mL/h) was started immedi-
ately and was maintained during the next 48 h. Pain intensity at 
rest, on movement, and with mobilization was estimated by the 
patients and the physiotherapist; rescue morphine consumption 
was recorded. 
Results   As estimated by the patients, ropivacaine administered 
intraarticularly did not improve analgesia relative to extraarticu-
lar infusion, but improved the first mobilization. The incidence 
of high intensity of pain (VAS 7–10) was less in the group with 
intraarticular infusion. Analgesic requirements were similar in 
the 2 groups (47 mg and 49 mg morphine). No complications of 
postoperative wound healing were seen and there were no toxic 
side effects. 
Interpretation   Continuous infusion of ropivacaine intraar-
ticulary did not improve postoperative analgesia at rest relative 
to extraarticular administration, but it appeared to reduce the 
incidence of high pain intensity during first exercises, and could 
therefore be expected to improve mobilization up to 24 h after 
total knee arthroplasty.   
Pain after total knee arthroplasty is severe in two-thirds of 
patients (Bonica 1984, Beattie et al. 1997). The pain may be a 
result of trauma to the bone or soft tissues or a result of hyper-
perfusion after tourniquet release (Estebe et al. 1995). The 
optimal form of pain relief is one that is applied preoperatively, 
perioperatively, and postoperatively to avoid the establish-
ment of pain hypersensitivity (Badner et al. 1996). Good pain 
relief allows effective postoperative rehabilitation (Shoji et al. 
1990). In contrast to epidural analgesia and femoral block, an 
alternative method to achieve good postoperative pain relief 
is local infiltration combined with single-shot injection or 
continuous infusion of local anesthetics into the surgical site. 
Local anesthetic infiltration is helpful in the management of 
postoperative pain after several orthopedic procedures (De 
Andres et al. 1993). The use of intraarticular analgesia to limit 
postoperative pain following knee arthroplasty has been inves-
tigated, with different results (Smith et al. 1991, Allen et al. 
1993, Osborne and Keene 1993, Badner et al. 1996, Mauerhan 
et al. 1997, Ritter et al. 1999).
A local infiltration analgesia (LIA) technique was devel-
oped by Kerr and Kohan in Sydney, Australia (Rostlund and 
Kehlet 2007, Kerr and Kohan 2008). With this technique, the 
long-acting local anesthetic ropivacaine, a non-steroidal anti-
inflammatory drug (ketorolac), and epinephrine are infiltrated 
periarticulary during surgery. An alternative technique that 
might have widespread applicability is the insertion of cath-
eters to allow continuous infusion of local anesthetics into the 
surgical wound at the end of the procedure. There is a need 
for detailed systematic studies to evaluate the optimal site 
of administration of local anaesthetics. In this randomized, 
double-blind study, we compared the analgesic effects of con-
tinuous infusion of local anesthetics either intraarticulary or 
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by using computer-generated random numbers inserted into 
sealed envelopes marked 1–36. The randomization envelope 
was opened a few minutes before the start of surgery. 
The patients, the 2 independent study investigators, the 
study physiotherapist, and all the staff concerned with the 
postoperative care of the patients were blinded. The operating 
surgeons who were not blinded did not take any part in patient 
care after completion of the operation. The key-list regarding 
randomization was opened only after the data from the last 
patient had been collected and recorded.
Anesthesia
All the patients received paracetamol (1 g) orally before 
planned surgery. A midline lumbar puncture was performed at 
the L3–L4 interspace with a 27-G Quincke spinal needle, with 
the patients in a sitting position, using 20 mg of plain bupi-
vacain (Marcain Spinal; Astra, Södertalje, Sweden). Noninva-
sive blood pressure was measured intraoperatively at 5-min 
intervals and heart rate (HR), respiratory rate, and SpO2 were 
registered continuously using Datex-Engstrom AS/3. Hypo-
tension was defined as a decrease in systolic blood pressure 
by 30% from the baseline value, and was treated with ephed-
rine (5 mg intravenously). Bradycardia was defined as HR 
< 50 beats/min, and was treated with atropine (0.5 mg intra-
venously). Intraoperative sedation was provided with propofol 
intravenously, with a target plasma concentration of 0.5–0.8 
Figure 1. Flow chart of the study.
Patients and methods
The study protocol was approved by 
the regional ethics committee (May 14, 
2009, FOUS09002) and the Swedish 
Medical Products Agency, and was con-
ducted in accordance with the Declara-
tion of Helsinki (ClinicalTrials identi-
fier: NCT01050738). Written informed 
consent was obtained from each patient 
before the start of the study.
50 patients with rheumatoid arthri-
tis who were scheduled for total knee 
arthroplasty were screened for eligibility. 
Inclusion criteria were age < 80 years, a 
weight of 50–120 kg, and an ability to 
provide informed consent for the study 
and to cooperate with study personnel. 
Exclusion criteria were major psycho-
logical problems, allergies to any of the 
ingredients of the injection, renal insuffi-
ciency, abnormal liver enzymes, a history 
of stroke or a major neurological deficit, 
uncontrolled angina, chronic opioid use, 
severe diabetes, inability to understand or 
use patient controlled analgesia (PCA), 
or any contraindications for spinal anes-
thesia. Elective unilateral total knee 
arthroplasty was performed at the Unit 
for Rheumatic Surgery, Spenshult Hospi-
tal from September 2009 through March 
2010 and patients were followed for 3 
months after surgery.
Randomization and blinding 
50 patients were assessed for eligibility 
and 14 were excluded before random-
ization (Figure 1). The 36 patients were 
randomly allocated to 1 of 2 treatment 
groups, each comprising 18 patients, 
Assessed for eligibility
(n = 50)
Excluded (n=14):
•  refused to participate (n=1)
•  severe diabetes (n=4)
•  spinal stenosis (n=3)
•  chronic opioid use (n=4)
•  allergy to ketorolac (n=2)
Randomized
(n=36)
Group I (n=18) Group E (n=18)
Total knee arthroplasty under spinal anesthesia.
Local infiltration of soft tissues:
•   300 mg ropivacaine (150 mL)
•   30 mg ketorolac (1 mL)
•   0.5 mg epinephrine (5 mL)
Placement of catheter with tip sited
intraarticulary
Placement of catheter with tip sited
extraarticulary
Preoperatively
Excluded (n=1)
Delayed start of infusion
Continuous infusion via
catheter: Ropivacaine
0.5% 2 mL/h
Excluded (n=1)
PainBuster disconnection
Excluded (n=1)
PainBuster disconnection
Data collection and recording
(n=16)
Data collection and recording
(n=17)
Intraoperatively
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µg/mL according to the patient’s needs. Intravenous fluids 
were administered in accordance with estimated blood loss.
Kloxacillin (2 g) was given intravenously before surgery 
and twice postoperatively, with 8-h intervals. For thrombopro-
phylaxis, rivaroxaban (10 mg), was administered orally once 
each evening for 14 days, starting on the day of surgery.
Surgery
The knee arthroplasty was performed by 1 of 2 surgeons using 
a standard medial parapatellar approach. The same technique 
was used in both groups, and all patients received the NexGen 
CR prosthesis (Zimmer Sweden AB). A tourniquet was used 
in all patients. 
Pain management 
At the end of the operation, the surgeon infiltrated a solu-
tion containing 300 mg ropivacaine (150 mL of 0.2% Narop 
(AstraZeneca, Sodertalje, Sweden), 30 mg Toradol (1 mL of 
Ketorolac; Roche AB, Stockholm, Sweden), and 0.5 mg epi-
nephrine (5 mL of 0.01% adrenaline) into the soft tissues peri-
articularly in the following way. The first aliquot of 30 mL of 
the mixture was injected, just prior to implantation of the com-
ponent, into the posterior aspect of the capsule and the medial 
and lateral collateral ligaments. 50 mL was injected into the 
deep tissues around the medial and collateral ligaments and 
the wound edges before suturing. The rest was injected into 
the capsule incision, the synovial sheet, the ligaments, and 
the subcutaneous tissue. Care was taken to avoid excessive 
infiltration in the area of the common peroneal nerve. Wound 
drains were not placed in any patients.
A multi-hole Perifix One catheter (B. Braun Medical AB, 
Danderyd, Sweden) was tunnelled laterally through muscle 
and skin, 6–8 cm from the edge of the wound. The tip of the 
catheter was placed according to randomization either in the 
distal part of the joint intraarticularly (the I group) or, in the 
case of an extraarticular location (the E group), the tip of the 
catheter was embedded into the soft tissues proximal to the 
patella. The medial split of the quadriceps tendon, the medial 
retinaculum, and the soft tissues medial to the patellar tendon 
were meticulously sutured with interrupted and continuous 
techniques, to prevent any communication between the joint 
space and the subcutaneous space. The catheter was connected 
to a pump (Pain Buster; I-Flow Corp., Lake Forest, CA). 
Thereafter, a continuous infusion of 5 mg/mL ropivacaine was 
started at 2 mL/h. 
Postoperative pain was treated using paracetamol (1 g orally 
every 6 h) in all patients. Pain intensity was assessed by VAS 
(where 0 = no pain and 10 = worst pain). When the patient 
had a VAS score at rest of ≥ 3, morphine (1 mg) was repeat-
edly administered intravenously until the score was < 3. Then 
all patients were provided with a PCA device programmed to 
deliver morphine (a morphine bolus of 1 mg, a lock-out of 6 
min, and a maximum of 10 mg/h) as a rescue medication for 
48 h after surgery. 
Outcome measures
The consumption of patient-controlled analgesia was mea-
sured hourly during the 48-h postoperative period and the 
patient’s overall analgesic consumption was measured to 
permit comparison between the 2 treatment groups. Patients 
used a visual analog scale to assess pain, both at rest and with 
motion. 
All patients were mobilized by a physiotherapist 24 h after 
surgery and then at 12-h intervals. Pain during mobilization 
was judged by the patients according to VAS score and by the 
physiotherapist according to Verbal Rating Score (VRS: 0 = 
none, 1 = mild, 2 = moderate, 3 = strong, 4 = intense, and 5 = 
unbearable). Pain intensity and need of rescue opioids during 
mobilization were recorded.
During the first 12 h postoperatively, mean arterial pressure, 
heart rate, oxygen saturation, and sedation were recorded 
every 2 h and then every 6 h thereafter. Sedation was assessed 
on a 4-point VRS (1 = no sedation, 2 = light sedation, 3 = 
somnolence, and 4 = deep sedation). The physiotherapists 
assessed knee flexion postoperatively and recorded patients’ 
ability to climb stairs (they were asked to climb a 4-step stair-
case without handrail support). 
The appearance of symptoms of central nervous system tox-
icity, such as numbness of the tongue, dizziness, visual distur-
bances, metallic taste, tinnitus, muscular twitching and dysar-
thria, or hemodynamic changes, were criteria for immediate 
discontinuation of ropivacaine infusion.
Discharge was decided by the surgeons who were blinded 
regarding the analgesic treatment, according to the following 
discharge criteria: (1) satisfactory pain control for self-mobil-
ity; (2) uncomplicated wound-healing process; (3) uncompli-
cated clinical and radiographic outcome; (4) no evidence of 
deep vein thrombosis; and (5) acceptable level of hemoglobin 
and liver/kidney function; and (5) ability for active flexion 
≥ 65 degrees. 
Statistics
Unless otherwise stated, the results are expressed as mean 
with 95% confidence interval or median (range). All normally 
distributed continuous variables were analyzed by one-way 
ANOVA followed by Tukey’s test. The degree of sedation and 
analgesia in the groups was assessed using the Mann-Whitney 
U-test. If there were significant differences, the analysis was 
continued with post hoc comparisons of differences between 
pairs of groups using the Mann-Whitney U-test. Fisher’s exact 
test was used to determine differences in all nominal data. Any 
p-value < 0.05 was considered statistically significant.
The aim was to determine whether either intraarticular or 
extraarticular administration of local anesthetics was superior 
to the other, with a null hypothesis of no difference between 
the two groups. Calculation of sample size was based on a 
minimum difference of 10 mm in the VAS measurement for 
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mal clinically important differences in acute pain (DeLoach et 
al. 1998), on a standard deviation of 16, with p = 0.80 and α = 
0.05. We obtained a sample size of 16 patients per group. A 
sample size of 18 patients per group was then chosen to ensure 
that the calculated number of patients would still be available 
by the final analysis. 
Results
Both groups were comparable with respect to age, height, 
body weight, ASA classification, time of operation and tour-
niquet release, dosage of local anesthetics and propofol, and 
time until the first dose of analgesic was applied. There were 
more females than males in both groups (Table). Subarach-
with no statistically significant differences (Table).
Primary endpoint, pain relief
The total amounts of PCA morphine required during the study 
period were compared for group I and group E. The over-
all analgesic consumption in rescue morphine was similar 
between the 2 groups: after 48 h, morphine consumption had 
reached 50 mg in both groups (Figure 2).
There was no statistically significant difference in VAS 
score—at rest or with movement—between the groups (the 
lowest p-value being 0.07; Figure 3). The mean visual analog 
scale rating for pain intensity at rest was < 3 (out of 10) during 
all the time of the investigation and the highest pain score 
in movement was observed between 24 h and 60 h, when it 
reached a maximum rating of 6. 
Demographic and intraoperative data on patients
  Group I  Group E  p-value
  (n=16) (n=17) 
Age, years    70 (64–76) a    64 (55–73)  0.2
Sex (M/F)      6/10      3/14  0.2
ASA physical status (II/III)     15/1    17/0  0.5
Length, cm  177 (170–184)  174 (163–184)  0.7
Weigh, kg    74 (60–89)    83 (71–95)  0.3
Duration of operation, min    89 (75–104)    92 (65–119)  0.7
Intraoperative dose of propofol, mg  188 (156–220)  179 (139–219)  0.4
Time to the first morphine request, min  436 (274–618)  449 (235–663)  0.9
a Values with parentheses are mean (95% CI)
Group I: intraarticular infusion of ropivacaine; group E: extraarticular infusion of ropivacaine; 
ASA physical status II: mild systemic disease; ASA physical status III: severe systemic disease.
noid block was successful for intraop-
erative analgesia in all cases. No addi-
tional analgesics were used during the 
operation.
3 patients were excluded from 
analysis. By mistake, 1 patient in the 
I group did not receive the continu-
ous postoperative infusion because 
the start of the infusion was delayed. 
1 patient in each study group was 
excluded because of catheter discon-
nection. Thus, 33 patients completed 
the study. Patient characteristics, dura-
tion of surgery, blood loss, and the 
intraoperative dose of propofol and 
ephedrine were similar in both groups 
Figure 2. Cumulative postoperative morphine (mg; mean ± 95% CI) 
during the first 48 postoperative hours after TKA. There were no signifi-
cant differences between group I (intraarticular infusion of ropivacaine) 
and group E (extraarticular infusion of ropivacaine).
Figure 3. Mean postoperative visual analog pain score (VAS; mean ± 
95% CI) assessed at rest and on passive movement at different times 
during the 48-h follow-up after TKA. No significant difference was 
recorded between groups.
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There was greater physiotherapist satisfaction concern-
ing the first mobilization in the I group (p < 0.05) (Figure 4). 
Patients in group I showed a trend toward lower mean scores 
during exercise at 48 h postoperatively (p < 0.07). 11 patients 
in the E group had severe pain at mobilization (VAS ≥ 7), as 
opposed to 3 patients in the I group (p = 0.03). The dose of 
morphine as rescue analgesic during mobilization was compa-
rable between groups and there was no statistically significant 
difference during all the time of the study (p = 0.8). 
Secondary endpoints
Postoperative knee flexion and time to climb stairs were simi-
lar between the groups. No serious side effects (respiratory or 
cardiovascular suppression) were observed in any patient, but 
side effects of minor importance occurred in both groups. Diz-
ziness was observed in more patients in the E group more often 
than in the I group (7 and 5 patients, respectively; p < 0.4). 
The frequency of other side effects such as nausea and pruri-
tus was unaffected by the treatment modality throughout the 
study period.
No neurological or cardiac complications could be attrib-
uted to ropivacaine administration. No signs of local or sys-
temic infections were noted in any of the patients, and wound 
healing was considered normal by the surgeon. The patients 
were ready for discharge after mean 70 h for the I group and 
74 h for the E group. No patients were re-admitted for any 
complications during the 6 months of follow-up.
Discussion
Although Andersen et al. (2008) reported that there was no 
difference in analgesic effect in administration of ropiva-
caine intraarticulary, or in the extraarticular wound space, our 
double-blind, randomized study has shown that postoperative 
mobilization after total knee arthroplasty can be improved by 
intraarticular application of local anesthetics. Our results may 
be due to a different design. We have not found any published 
studies evaluating the effect of continuous intraarticular infu-
sion of local anesthetics after TKA.
Direct application of local anesthetic in wounds can pro-
vide analgesia through several mechanisms. Local anesthetics 
would directly block transmission of pain from nociceptive 
afferents from the wound surface. In addition, there is growing 
evidence that local anesthetic can inhibit local inflammatory 
responses to injury, which can sensitize nociceptive receptors 
and contribute to pain and hyperalgesia. For example, local 
anesthetics can reduce release of inflammatory mediators from 
neutrophils, reduce neutrophil adhesion to the endothelium, 
reduce formation of free oxygen radicals, and reduce edema 
formation (Hollmann and Durieux 2000, Hahnenkamp et al. 
2002). Regardless of mechanisms, the ability to provide pro-
longed application of local anesthetics to wounds through a 
catheter is probably important, as previous systematic reviews 
have been unable to detect any appreciable benefit from single 
injection of local anesthetics in abdominal operation or lapa-
roscopy (Moiniche et al. 1998, 2000). In the present study, 
ropivacaine infused intraarticulary did not reduce either mean 
VAS or morphine consumption, but the number of patients 
with a high level of pain intensity differed depending on the 
site of administration of local anesthetic.
Ropivacaine is pharmacologically similar to bupivacaine, 
but is associated with less cardiac and central nervous system 
toxicity, which allows patients to tolerate a larger dose (Mather 
et al. 2005, Mather 2010). Although the main action of ropi-
vacaine is to block afferent peripheral nociceptive activity, 
the drug has also been shown to have some anti-inflammatory 
properties in human mucosal cells (Martinsson et al. 1997). 
Our patients received an initial dose of 300 mg ropivacaine 
followed by 10 mg/h, i.e. 540 mg of ropivacaine over the first 
24 h (or altogether 780 mg in 48 h). One of several limitations 
in our study was that we did not check ropivacaine concen-
tration in plasma. However, our dosages of ropivacaine were 
not higher than used in other studies. No toxic blood levels of 
ropivacaine were measured in the study by Busch et al. (2006) 
(using 400 mg ropivacaine for infiltration), or in the study by 
Vendittoli et al. (2006) (using 400 mg ropivacaine for infiltra-
tion and 150 mg for injection on the following day). None 
of the patients reported tinnitus, tingling, perioral numbness, 
or other toxic symptoms of local anesthetics. We used epi-
nephrine intraoperatively, which reduces the toxicity of the 
local anesthetic by keeping it localized to the area of injection 
(Solanki et al. 1992). The maximum tolerated doses of local 
Figure 4. Box plots showing intensity of pain during exercise estimated 
by physiotherapists according to Verbal Rating Score (0 = none, 1  = 
mild, 2 = moderate, 3 = strong, 4 = intense, and 5 = unbearable) in 
group I (intraarticular infusion of ropivacaine) and group E (extraar-
ticular infusion of ropivacaine). The boxes show the interquartile range, 
and the whiskers the minimum and maximum values.
Group E
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4
3
2
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5
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anesthetics with epinephrine administered intraarticulary or 
by infiltration have not been properly established (Rosenberg 
et al. 2004). The use of epinephrine in the ropivacaine injec-
tion may have reduced bleeding into the knee, but because 
neither group of patients had drains, there was no way of 
ascertaining whether any of the patients had reduced bleeding 
into the knee. 
Our findings are consistent with the results of 2 recent stud-
ies in which patients were randomized to receive either periar-
ticular or intraarticular treatment and patient-controlled anal-
gesia (PCA) with morphine, or PCA alone (Busch et al. 2006, 
Vendittoli et al. 2006). Both studies assessed infiltration with 
ropivacaine, ketorolac, and epinephrine, though Busch et al. 
added epimorphine to the solution and Vendittoli et al. added 
a postoperative bolus through an intraarticular catheter. The 
study by Busch et al. included 64 patients who were blinded 
(as was the postoperative team), and the study by Vendittoli et 
al. included 42 patients. The positive results of these 2 studies 
are not surprising, as the analgesic treatment in the control 
groups mainly consisted of parenteral morphine.
According to previously published studies, the cumulative 
24-h morphine consumption has been reduced from 40–60 mg 
(Sites et al. 2003, Stiller et al. 2007) to 30 mg (Vendittoli et al. 
2006) by using LIA technique. In the present study, continu-
ous postoperative infusion of ropivacaine in combination with 
LIA allowed a reduction of the 24-h dose of morphine, of up 
to 20 mg in both groups. Opioid-sparing provided objective 
evidence of efficacy of continuous wound catheters and prob-
ably contributed to reduced incidence of postoperative nausea 
and vomiting (PONV). With incidence ranging from 30% to 
80% (Gan et al. 2003), PONV has been consistently rated 
by patients as a primary concern after operation that is more 
important than postoperative pain (Gan et al. 2003, Apfel et al. 
2004). The patients in our study had a low incidence of PONV 
(4/33), which corresponds to a low dose of morphine. PONV 
can result in major patient discomfort, poor satisfaction, and 
increased economic burden, as it has been identified as a major 
cause of increased nursing care and delayed discharge.
Early mobilization is important after TKA. Effective exer-
cises with physiotherapists reduce the risk of complications 
such as deep vein thrombosis, pulmonary embolism, pneumo-
nia, and urinary retention (Beard et al. 2002). In our study, 
postoperative intraarticular infusion of ropivacaine was not 
clearly superior to extraarticular infusion during all mobiliza-
tions, but it gave improved pain relief 24 h after the operation.   
The incidences of technical failure (2/33) or local anesthetic 
toxicity (0/33) from wound catheters were low in our study. 
One possible concern about this technique is the potential risk 
of delayed wound healing and infection. The size of our study 
does not allow conclusions to be drawn regarding the risk of 
deep knee infection. The data in the literature about this com-
plication are controversial. Several authors have expressed 
potential concern about wound infections from the presence 
of a catheter. (Brown and Morrison 2004) reported that rates 
of superficial wound infection were similar between active 
(0.7%) and control groups (1.2%), while in another studies 
with the intraarticular catheter in place for 48 h, 55 h, and 72 
h, no increased risk of infection was found (Bianconi et al. 
2003, Rasmussen et al. 2004, Vendittoli et al. 2006). 
One limitation of the present study was the low number of 
patients, and the results must be interpreted with this in mind. 
Positive findings at the 5% significance level should be inter-
preted with caution, due to multiple comparisons. 
In conclusion, we found that continuous infusion of ropiva-
caine intraarticulary did not improve postoperative analgesia 
at rest compared to extraarticular infusion, but it appeared to 
reduce the incidence of high pain intensity during first exer-
cises. It could therefore be expected to improve mobilization 
within 24 hours after total knee arthroplasty. 
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